Fitness Training Using WBEMS Among Individuals With SCI

March 30, 2021 updated by: University Health Network, Toronto

Physical Fitness Training Using Whole-Body Electrical Muscle Stimulation Among Individuals Living With Chronic Spinal Cord Injury

Up to 15 individuals living with chronic SCI will be recruited for this study. Each participant will complete an initial clinical assessment before starting a 10-week training program. The training program will consist of three 45-minute Whole-Body Electrical Muscle Stimulation (WBEMS)-augmented exercise training sessions for 10 weeks. At each training session, all adverse events (pain, redness, injury, etc.) will be recorded along with participants' comments concerning comfort (i.e. Objective 1). The investigators hypothesize that the use of a WBEMS will result in no serious adverse effect during and following the training sessions and that it will take less than 10 minutes to don and doff the suit.

At the fifth session, after participants have had the opportunity to become familiar with the WBEMS intervention, the immediate effects of the intervention on physiological responses will be assessed (i.e. Objective 2). It is hypothesized that during a single training session consisting of WBEMS and exercise, physiological responses and energy expenditure (EE) will be significantly improved in participants with SCI compared to a training session consisting solely of exercises without WBEMS.

At the end of the training program, participants will complete the final clinical assessment to evaluate the therapeutic benefit of the WBEMS-augmented exercise intervention (i.e. Objective 3). Three months after the end of the training program, the participants will be asked to complete a semi-structured interview and questionnaire to evaluate the perceived benefits of the training program (i.e. Objective 3).It is also hypothesized that participants will perceive benefits of the 10-week training program such as decreased spasticity, increased energy and improved mood.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

1

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M4G 3V9
        • Lyndhurst Centre, Toronto Rehabilitation Institute-UHN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. have a motor complete SCI (i.e., American Spinal Injury Association Impairment Scale grade A or B which means complete motor paralysis below the level of injury) at the neurological level T7 or below (i.e., to avoid triggering autonomic dysreflexia). The participants will have complete motor function of their arms but not of their legs;
  2. be at least one year post-injury (i.e., chronic injury);
  3. be between 18 and 65 years of age;
  4. be cleared for physical activity based on The Physical Activity Readiness Questionnaire for Everyone (PAR-Q+)34
  5. be able to provide informed, written consent.

Exclusion Criteria:

1) Contraindications for EMS35,36. Electrical stimulation should not be applied:

  • if implanted electronic devices, including cardiac pacemakers
  • if coronary stents are present
  • if cosmetics and other implants are present in the application region
  • to pregnant women
  • on the regions of known or suspected malignancy
  • if active deep vein thrombosis or thrombophlebitis
  • to actively bleeding tissue or to persons with untreated hemorrhagic disorders
  • to infected tissues, tuberculosis, or wounds with underlying osteomyelitis
  • if inflammation is present in the region of application
  • to recently radiated tissues
  • to the chest in persons with cardiac disease, arrhythmias, or heart failure
  • to the neck or head region of persons known to have seizures
  • transcranially without specialized training
  • to areas near reproductive organs or genitalia without specialized training
  • to areas near or over eyes
  • to anterior neck or carotid sinus
  • to damaged or at-risk skin areas that would result in uneven conduction of current (excluding open wounds where the specific intent is to use electrical stimulation for tissue healing)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of Training Session
Time Frame: For the 30 training sessions spread over 10 weeks
Time in minutes
For the 30 training sessions spread over 10 weeks
Intensity of Training Session
Time Frame: For the 30 training sessions spread over 10 weeks
Type of activity; repetitions; weight resistance
For the 30 training sessions spread over 10 weeks
Adverse Events
Time Frame: For the 30 training sessions spread over 10 weeks, if necessary
All adverse events, even minor, will be reported in the intervention CRF, and compiled in a specific document (Adverse Event Report Form) all along the study to be analyzed as an outcome of the study
For the 30 training sessions spread over 10 weeks, if necessary

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: Up to 10 weeks
Up to 10 weeks
Height
Time Frame: Up to 10 weeks
Up to 10 weeks
Body Mass Index
Time Frame: Up to 10 weeks
Up to 10 weeks
Anthropometric data
Time Frame: Up to 10 weeks
Circumference of the waist, abdominal region, thighs, legs, arms and forearms
Up to 10 weeks
Maximal Isometric Voluntary Strength
Time Frame: Up to 10 weeks
Maximal strength of the major muscle groups of upper extremity (i.e., flexors, extensors and abductors of the shoulder, and flexors and extensors of the elbow) will be measured using hand-held dynamometer
Up to 10 weeks
Exercise Self-Efficacy Questionnaire
Time Frame: Up to 10 weeks
Used to assess the perception and confidence to do leisure time physical activity
Up to 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

December 31, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

March 5, 2020

First Submitted That Met QC Criteria

March 10, 2020

First Posted (Actual)

March 13, 2020

Study Record Updates

Last Update Posted (Actual)

April 1, 2021

Last Update Submitted That Met QC Criteria

March 30, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on StimaWell®EMS

3
Subscribe